These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 28694238)

  • 1. Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.
    Kozlowska AK; Florczak A; Smialek M; Dondajewska E; Mackiewicz A; Kortylewski M; Dams-Kozlowska H
    Acta Biomater; 2017 Sep; 59():221-233. PubMed ID: 28694238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalized spider silk spheres as drug carriers for targeted cancer therapy.
    Florczak A; Mackiewicz A; Dams-Kozlowska H
    Biomacromolecules; 2014 Aug; 15(8):2971-81. PubMed ID: 24963985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of spider silk sphere formation processing conditions to obtain carriers with controlled characteristics.
    Florczak A; Jastrzebska K; Bialas W; Mackiewicz A; Dams-Kozlowska H
    J Biomed Mater Res A; 2018 Dec; 106(12):3211-3221. PubMed ID: 30242958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blending two bioengineered spider silks to develop cancer targeting spheres.
    Florczak A; Jastrzebska K; Mackiewicz A; Dams-Kozlowska H
    J Mater Chem B; 2017 Apr; 5(16):3000-3011. PubMed ID: 32263992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The method of purifying bioengineered spider silk determines the silk sphere properties.
    Jastrzebska K; Felcyn E; Kozak M; Szybowicz M; Buchwald T; Pietralik Z; Jesionowski T; Mackiewicz A; Dams-Kozlowska H
    Sci Rep; 2016 Jun; 6():28106. PubMed ID: 27312998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioengineering the spider silk sequence to modify its affinity for drugs.
    Kucharczyk K; Weiss M; Jastrzebska K; Luczak M; Ptak A; Kozak M; Mackiewicz A; Dams-Kozlowska H
    Int J Nanomedicine; 2018; 13():4247-4261. PubMed ID: 30050299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composite spheres made of bioengineered spider silk and iron oxide nanoparticles for theranostics applications.
    Kucharczyk K; Rybka JD; Hilgendorff M; Krupinski M; Slachcinski M; Mackiewicz A; Giersig M; Dams-Kozlowska H
    PLoS One; 2019; 14(7):e0219790. PubMed ID: 31306458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities.
    Kortylewski M; Moreira D
    Cancer Immunol Immunother; 2017 Aug; 66(8):979-988. PubMed ID: 28214929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of chemotherapeutics using spheres made of bioengineered spider silks derived from MaSp1 and MaSp2 proteins.
    Jastrzebska K; Florczak A; Kucharczyk K; Lin Y; Wang Q; Mackiewicz A; Kaplan DL; Dams-Kozlowska H
    Nanomedicine (Lond); 2018 Feb; 13(4):439-454. PubMed ID: 29338625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGD-functionalized bioengineered spider dragline silk biomaterial.
    Bini E; Foo CW; Huang J; Karageorgiou V; Kitchel B; Kaplan DL
    Biomacromolecules; 2006 Nov; 7(11):3139-45. PubMed ID: 17096543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR9-Targeted SiRNA Delivery In Vivo.
    Hossain DM; Moreira D; Zhang Q; Nechaev S; Swiderski P; Kortylewski M
    Methods Mol Biol; 2016; 1364():183-96. PubMed ID: 26472451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo study of the immune response to bioengineered spider silk spheres.
    Deptuch T; Penderecka K; Kaczmarek M; Molenda S; Dams-Kozlowska H
    Sci Rep; 2022 Aug; 12(1):13480. PubMed ID: 35931709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facile preparation of recombinant spider eggcase silk spheres via an HFIP-on-Oil approach.
    Chen J; Hu J; Zuo P; Shi J; Yang M
    Int J Biol Macromol; 2018 Sep; 116():1146-1152. PubMed ID: 29782985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial coating of spider silk to prevent bacterial attachment on silk surgical sutures.
    Franco AR; Fernandes EM; Rodrigues MT; Rodrigues FJ; Gomes ME; Leonor IB; Kaplan DL; Reis RL
    Acta Biomater; 2019 Nov; 99():236-246. PubMed ID: 31505301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface Modification of Spider Silk Particles to Direct Biomolecular Corona Formation.
    Weiss ACG; Herold HM; Lentz S; Faria M; Besford QA; Ang CS; Caruso F; Scheibel T
    ACS Appl Mater Interfaces; 2020 Jun; 12(22):24635-24643. PubMed ID: 32369330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthermia treatment of cancer cells by the application of targeted silk/iron oxide composite spheres.
    Kucharczyk K; Kaczmarek K; Jozefczak A; Slachcinski M; Mackiewicz A; Dams-Kozlowska H
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111654. PubMed ID: 33545822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between spider silk and cells--NIH/3T3 fibroblasts seeded on miniature weaving frames.
    Kuhbier JW; Allmeling C; Reimers K; Hillmer A; Kasper C; Menger B; Brandes G; Guggenheim M; Vogt PM
    PLoS One; 2010 Aug; 5(8):e12032. PubMed ID: 20711495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Engineered spider silk: the intelligent biomaterial of the future. Part II].
    Kaźmierska K; Florczak A; Piekoś K; Mackiewicz A; Dams-Kozłowska H
    Postepy Hig Med Dosw (Online); 2011 Jun; 65():389-96. PubMed ID: 21734323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Processing and Modification of Recombinant Spider Silk Proteins].
    Liu B; Wang T; Liu X; Luo Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Aug; 32(4):933-9. PubMed ID: 26710473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.